Volume 9, Issue 4, Pages (April 2004)

Slides:



Advertisements
Similar presentations
The distribution and function of the Adenovirus L4-33K protein
Advertisements

Volume 3, Issue 6, Pages (June 2001)
Volume 2, Issue 1, Pages (July 2000)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Pericentrosomal Localization of the TIG3 Tumor Suppressor Requires an N-Terminal Hydrophilic Region Motif  Tiffany M. Scharadin, Gautam Adhikary, Kristin.
Self-Excising Retroviral Vectors Encoding the Cre Recombinase Overcome Cre- Mediated Cellular Toxicity  Daniel P. Silver, David M. Livingston  Molecular.
Volume 9, Issue 4, Pages (April 2004)
Volume 1, Issue 6, Pages (May 1998)
Volume 3, Issue 5, Pages (May 2008)
Robert E. White, Richard Wade-Martins, Michael R. James 
Volume 7, Issue 6, Pages (June 2001)
Volume 16, Issue 3, Pages (March 2008)
Volume 10, Issue 4, Pages (October 2004)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Volume 10, Issue 5, Pages (November 2004)
Volume 3, Issue 5, Pages (May 2008)
Human Papilloma Virus E6 and E7 Proteins Support DNA Replication of Adenoviruses Deleted for the E1A and E1B Genes  Dirk S. Steinwaerder, Cheryl A. Carlson,
Volume 13, Issue 2, Pages (February 2006)
Efficient Gene Transfer to Human Epidermal Keratinocytes on Fibronectin: In Vitro Evidence for Transduction of Epidermal Stem Cells  Bharat G. Bajaj,
Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF)
Volume 14, Issue 1, Pages (July 2006)
M.Brandon Parrott, Michael A. Barry  Molecular Therapy 
Volume 6, Issue 2, Pages (August 2002)
Volume 2, Issue 1, Pages (July 2000)
Volume 20, Issue 5, Pages (May 2012)
Volume 9, Issue 4, Pages (April 2004)
Volume 2, Issue 3, Pages (September 2000)
Volume 7, Issue 1, Pages (January 2003)
Profilaggrin Requires both Linker and Filaggrin Peptide Sequences to Form Granules: Implications for Profilaggrin Processing In Vivo1  Melanie K. Kuechle,
Volume 5, Issue 2, Pages (February 2002)
Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53  Yanping Zhang, Yue Xiong 
Volume 22, Issue 4, Pages (April 2014)
Xiuwu Zhang, Chuan-Yuan Li  Molecular Therapy 
In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis
Adenovirus Virion Stability and the Viral Genome: Size Matters
Kailin Xu, Hong Ma, Thomas J. McCown, Inder M. Verma, Tal Kafri 
Volume 26, Issue 4, Pages (April 2018)
Receptor-Targeted Gene Delivery Using Multivalent Phagemid Particles
J.P O'Rourke, H Hiraragi, K Urban, M Patel, J.C Olsen, B.A Bunnell 
Volume 12, Issue 5, Pages (November 2005)
Volume 12, Issue 2, Pages (August 2005)
Volume 8, Issue 6, Pages (December 2003)
Volume 12, Issue 5, Pages (November 2005)
Inclusion of jaagsiekte sheep retrovirus proviral elements markedly increases lentivirus vector pseudotyping efficiency  Patrick L. Sinn, Erin R. Burnight,
Volume 10, Issue 4, Pages (October 2004)
Improved Retinal Transduction In Vivo and Photoreceptor-specific Transgene Expression Using Adenovirus Vectors With Modified Penton Base  Siobhan M Cashman,
Robyn P. Hickerson, Frances J. D. Smith, Robert E
Volume 12, Issue 4, Pages (October 2005)
Volume 6, Issue 5, Pages (November 2002)
Volume 11, Issue 6, Pages (June 2005)
Volume 15, Issue 11, Pages (November 2007)
Changyu Zheng, Bruce J. Baum  Molecular Therapy 
Volume 6, Issue 3, Pages (September 2002)
Volume 10, Issue 6, Pages (December 2004)
Volume 9, Issue 3, Pages (March 2004)
Quan Jin, Chunping Qiao, Jianbin Li, Juan Li, Xiao Xiao 
Volume 4, Issue 4, Pages (October 2001)
Single-Shot, Multicycle Suicide Gene Therapy by Replication-Competent Retrovirus Vectors Achieves Long-Term Survival Benefit in Experimental Glioma  Chien-Kuo.
Volume 9, Issue 2, Pages (February 2004)
In Vivo Gene Delivery to Synovium by Lentiviral Vectors
Long-Term and Therapeutic-Level Hepatic Gene Expression of Human Factor IX after Naked Plasmid Transfer in Vivo  Carol H. Miao, Arthur R. Thompson, Keith.
Evidence for Encapsidation of Prokaryotic Sequences during Recombinant Adeno- Associated Virus Production and Their in Vivo Persistence after Vector Delivery 
Volume 9, Issue 5, Pages (May 2004)
Volume 3, Issue 1, Pages 8-13 (January 2001)
Volume 8, Issue 1, Pages (July 2003)
Biao Dong, Hiroyuki Nakai, Weidong Xiao  Molecular Therapy 
Molecular Therapy - Methods & Clinical Development
Volume 13, Issue 1, Pages (January 2006)
Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter  Lawrence E Ostrowski, James R Hutchins,
Volume 14, Issue 1, Pages (July 2006)
Presentation transcript:

Volume 9, Issue 4, Pages 617-624 (April 2004) Use of adenovirus protein IX (pIX) to display large polypeptides on the virion— generation of fluorescent virus through the incorporation of pIX-GFP  Robert A Meulenbroek, Kathy L Sargent, John Lunde, Bernard J Jasmin, Robin J Parks  Molecular Therapy  Volume 9, Issue 4, Pages 617-624 (April 2004) DOI: 10.1016/j.ymthe.2004.01.012 Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 1 Schematic representation of Ad vectors used in this study. Ad/pIX is deleted of the Ad early region 1 (E1) and E3 regions and encodes a C-terminal FLAG-tagged pIX under endogenous regulation. Ad/pIX-GFP is similar to Ad/pIX, but encodes a pIX-GFP fusion, as described under Materials and Methods. AdCMV-GFP is deleted of E1 and E3 and encodes GFP under the regulation of the human cytomegalovirus immediate-early promoter/enhancer and bovine growth hormone polyadenylation sequence (not shown). pIX in this vector is unaltered. AdRP2309a is a helper virus for use in the Cre/lox system for generating hdAd and encodes a pIX-GFP fusion protein as described for Ad/pIX-GFP. AdRP2309a contains a floxed packaging signal, is deleted of E1, contains the E4 open reading frame 6 (E4orf6) under the regulation of the mouse mammary tumor virus long terminal repeat within the E3 region, and is deleted of the native E4orf6, as has been previously described [4]. Molecular Therapy 2004 9, 617-624DOI: (10.1016/j.ymthe.2004.01.012) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 2 Expression of pIX in vitro. A549 cells were transiently transfected with plasmid expressing pIX-GFP (A–C), GFP (D–F), or pIX-FLAG (G–I). Twenty-four hours posttransfection, the cells were fixed and stained with Hoechst to visualize the cell nuclei. For cells transfected with pIX-FLAG, the protein was detected using immunofluorescence with an anti-FLAG antibody. Molecular Therapy 2004 9, 617-624DOI: (10.1016/j.ymthe.2004.01.012) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 3 Fluorescent visualization of Ad/pIX-GFP. Virus was propagated in 293 cells, and the virus was purified by cesium chloride buoyant density centrifugation, as described under Materials and Methods. Molecular Therapy 2004 9, 617-624DOI: (10.1016/j.ymthe.2004.01.012) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 4 Incorporation of pIX-GFP in the Ad virion. Ad/pIX or Ad/pIX-GFP (2.5 × 107 pfu) was heated in SDS–PAGE protein loading buffer and separated by 15% PAGE. The resulting proteins were transferred to a PVDF membrane and probed with antibody to FLAG (top) or Ad 5 fiber (bottom). The bands corresponding to pIX and pIX-GFP are indicated with arrows. Molecular Therapy 2004 9, 617-624DOI: (10.1016/j.ymthe.2004.01.012) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 5 In vitro visualization of Ad/pIX-GFP. A549 cells were infected with AdCMV-GFP or Ad/pIX-GFP at a multiplicity of infection of approximately 800 particles per cell and, 10 or 40 min later, the cells were fixed and stained with Hoechst, and GFP fluorescence was visualized by microscopy. Molecular Therapy 2004 9, 617-624DOI: (10.1016/j.ymthe.2004.01.012) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions

Fig. 6 In vivo visualization of Ad/pIX-GFP. Top: Adult C57Bl/6J mice were injected in the tibialis anterior muscle with 2.5 × 107 pfu of Ad/pIX-GFP. Thirty minutes later, the muscle was removed, embedded in OTC, and frozen in melting isopentane precooled by liquid nitrogen. Sections of the tissue were prepared and fluorescence was visualized by microscopy. Bottom: To examine the pathology of injected muscle, tissue sections were stained with hematoxylin and eosin. Molecular Therapy 2004 9, 617-624DOI: (10.1016/j.ymthe.2004.01.012) Copyright © 2004 The American Society of Gene Therapy Terms and Conditions